893 related articles for article (PubMed ID: 20087937)
21. Bone marrow transplantation from a pediatric donor with a high frequency of cytomegalovirus-specific T-cells.
Komatsu H; Kogawa K; Nonoyama S; Inui A; Sogo T; Fujisawa T; Klenerman P
J Med Virol; 2006 Dec; 78(12):1616-23. PubMed ID: 17063516
[TBL] [Abstract][Full Text] [Related]
22. Patterns of cytomegalovirus reactivation are associated with distinct evolutive profiles of immune reconstitution after allogeneic hematopoietic stem cell transplantation.
Moins-Teisserenc H; Busson M; Scieux C; Bajzik V; Cayuela JM; Clave E; de Latour RP; Agbalika F; Ribaud P; Robin M; Rocha V; Gluckman E; Charron D; Socié G; Toubert A
J Infect Dis; 2008 Sep; 198(6):818-26. PubMed ID: 18666855
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of human cytomegalovirus-specific CD8+ T-cells in allogeneic haematopoietic stem cell transplant recipients using pentamer and interferon-γ-enzyme-linked immunospot assays.
Liu A; Ma Y; Wu W; Chen X; Huang Y; Hu J; Liang H; Wang H; Yang R; Fan J
J Clin Virol; 2013 Oct; 58(2):427-31. PubMed ID: 23910932
[TBL] [Abstract][Full Text] [Related]
24. Reconstitution of CMV pp65 and IE-1-specific IFN-γ CD8(+) and CD4(+) T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT.
Tormo N; Solano C; Benet I; Nieto J; de la Cámara R; López J; Garcia-Noblejas A; Muñoz-Cobo B; Costa E; Clari MA; Hernández-Boluda JC; Remigia MJ; Navarro D
Bone Marrow Transplant; 2011 Nov; 46(11):1437-43. PubMed ID: 21243030
[TBL] [Abstract][Full Text] [Related]
25. Generation of HCMV-specific T-cell lines from seropositive solid-organ-transplant recipients for adoptive T-cell therapy.
Brestrich G; Zwinger S; Roemhild A; Noutsias M; Rohde M; Keeren K; Sawitzki B; Volk HD; Reinke P; Hammer MH
J Immunother; 2009; 32(9):932-40. PubMed ID: 19816188
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of cytomegalovirus (CMV)-specific T cell immune reconstitution revealed that baseline antiviral immunity, prophylaxis, or preemptive therapy but not antithymocyte globulin treatment contribute to CMV-specific T cell reconstitution in kidney transplant recipients.
Abate D; Saldan A; Fiscon M; Cofano S; Paciolla A; Furian L; Ekser B; Biasolo MA; Cusinato R; Mengoli C; Bonfante L; Rossi B; Rigotti P; Sgarabotto D; Barzon L; Palù G
J Infect Dis; 2010 Aug; 202(4):585-94. PubMed ID: 20594105
[TBL] [Abstract][Full Text] [Related]
27. Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants.
Aubert G; Hassan-Walker AF; Madrigal JA; Emery VC; Morte C; Grace S; Koh MB; Potter M; Prentice HG; Dodi IA; Travers PJ
J Infect Dis; 2001 Oct; 184(8):955-63. PubMed ID: 11574909
[TBL] [Abstract][Full Text] [Related]
28. Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy.
Peggs KS; Mackinnon S
Hum Immunol; 2004 May; 65(5):550-7. PubMed ID: 15172456
[TBL] [Abstract][Full Text] [Related]
29. Assessment of cellular immunity to human cytomegalovirus in recipients of allogeneic stem cell transplants.
Lacey SF; Diamond DJ; Zaia JA
Biol Blood Marrow Transplant; 2004 Jul; 10(7):433-47. PubMed ID: 15205665
[TBL] [Abstract][Full Text] [Related]
30. Donor serostatus has an impact on cytomegalovirus-specific immunity, cytomegaloviral disease incidence, and survival in seropositive hematopoietic cell transplant recipients.
Ugarte-Torres A; Hoegh-Petersen M; Liu Y; Zhou F; Williamson TS; Quinlan D; Sy S; Roa L; Khan F; Fonseca K; Russell JA; Storek J
Biol Blood Marrow Transplant; 2011 Apr; 17(4):574-85. PubMed ID: 20688181
[TBL] [Abstract][Full Text] [Related]
31. Cellular immune parameters associated with spontaneous control of CMV in children who underwent transplantation.
Guérin V; Dalle JH; Pédron B; Ouachée-Chardin M; Yakouben K; Baruchel A; Sterkers G
Bone Marrow Transplant; 2010 Mar; 45(3):442-9. PubMed ID: 19633694
[TBL] [Abstract][Full Text] [Related]
32. Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease.
Bordon V; Bravo S; Van Renterghem L; de Moerloose B; Benoit Y; Laureys G; Dhooge C
Transpl Infect Dis; 2008 Feb; 10(1):19-23. PubMed ID: 17511814
[TBL] [Abstract][Full Text] [Related]
33. Cytomegalovirus-specific CD8+ T cells do not develop in all renal transplant patients at risk of virus infection.
Christmas SE; Halliday D; Lawton N; Wang H; Abdalla I; Masters J; Hassan RL; Hart IJ; Khan N; Smith J; Hammad A; Bakran A
Transpl Immunol; 2009 Dec; 22(1-2):99-104. PubMed ID: 19635559
[TBL] [Abstract][Full Text] [Related]
34. Deficiency of cytomegalovirus (CMV)-specific CD8+ T cells in patients presenting with late-onset CMV disease several years after transplantation.
Cummins NW; Deziel PJ; Abraham RS; Razonable RR
Transpl Infect Dis; 2009 Feb; 11(1):20-7. PubMed ID: 18811629
[TBL] [Abstract][Full Text] [Related]
35. QuantiFERON®-CMV assay for the assessment of cytomegalovirus cell-mediated immunity.
Giulieri S; Manuel O
Expert Rev Mol Diagn; 2011 Jan; 11(1):17-25. PubMed ID: 21171917
[TBL] [Abstract][Full Text] [Related]
36. A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection.
Eid AJ; Brown RA; Arthurs SK; Lahr BD; Eckel-Passow JE; Larson TS; Razonable RR
Transpl Int; 2010 May; 23(5):506-13. PubMed ID: 19951371
[TBL] [Abstract][Full Text] [Related]
37. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
[TBL] [Abstract][Full Text] [Related]
38. Cytomegalovirus-specific immune recovery following allogeneic HLA-identical sibling transplantation with reduced-intensity preparative regimen.
Mohty M; Mohty AM; Blaise D; Faucher C; Bilger K; Isnardon D; Sainty D; Gastaut JA; Viens P; Olive D; Gaugler B
Bone Marrow Transplant; 2004 Apr; 33(8):839-46. PubMed ID: 14767500
[TBL] [Abstract][Full Text] [Related]
39. Cytomegalovirus-specific T cell immunotherapy promotes restoration of durable functional antiviral immunity following allogeneic stem cell transplantation.
Peggs KS; Verfuerth S; Pizzey A; Chow SL; Thomson K; Mackinnon S
Clin Infect Dis; 2009 Dec; 49(12):1851-60. PubMed ID: 19911966
[TBL] [Abstract][Full Text] [Related]
40. CMV-specific T-cell immunity, viral load, and clinical outcome in seropositive renal transplant recipients: a pilot study.
Sund F; Lidehäll AK; Claesson K; Foss A; Tötterman TH; Korsgren O; Eriksson BM
Clin Transplant; 2010; 24(3):401-9. PubMed ID: 19222507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]